To verify whether AKAP1 up-regulation could mitigate the AF risk and restore the MQS system in ibrutinib-treated mice models, we established an in vivo AKAP1 overexpression model using adeno-associated virus (AAV), with AAV-GFP as the control group. This evidence concerns the gene AKAP1 and atrial fibrillation.